1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with eliprodil in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (eliprodil) | Trials (eliprodil) | Recent Studies (post-2010) (eliprodil) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 104 | 3 | 23 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | eliprodil (IC50) |
|---|---|---|---|
| N-methyl-D-aspartate receptor | Sus scrofa (pig) | 0.0826 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 3.3 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 3.3 | |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 1.4 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 3.3 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 1.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benavides, J; Gotti, B; MacKenzie, ET; Scatton, B | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and eliprodil
| Article | Year |
|---|---|
The pharmacotherapy of focal cortical ischaemia in the mouse.
Topics: Animals; Calcium Channel Blockers; Cell Survival; Cyclandelate; Ischemic Attack, Transient; Male; Mice; Molecular Structure; N-Methylaspartate; Piperidines; Platelet Activating Factor; Receptors, GABA-A; Receptors, Opioid; Receptors, sigma; Vincamine | 1990 |